| Ex-Date | Pay Date | Amount | Change |
|---|---|---|---|
| CN¥0.49 | 72.96% | ||
| CN¥0.49 | 72.96% | ||
| CN¥0.2833 | 37.79% | ||
| CN¥0.2833 | 37.79% | ||
| CN¥0.2056 | 32.13% | ||
| CN¥0.1556 | |||
Eyebright Medical Technology (Beijing) Co Ltd Class A pays a dividend yield (FWD) of 0.53%.
- ISIN
- WKN
- Symbol / Exchange
- / XSHG
- Value
- €11.50
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Within the last 12 months, Eyebright Medical Technology (Beijing) Co Ltd Class A paid a dividend of CN¥0.49. For the next 12 months, Eyebright Medical Technology (Beijing) Co Ltd Class A is expected to pay a dividend of CN¥0.49. This corresponds to a dividend yield of approximately 0.53%.
- The dividend yield of Eyebright Medical Technology (Beijing) Co Ltd Class A is currently 0.53%.
- Eyebright Medical Technology (Beijing) Co Ltd Class A pays annually dividends. Payout is in June.
- The next dividend for Eyebright Medical Technology (Beijing) Co Ltd Class A is expected in June.
- Within the last 10 years, Eyebright Medical Technology (Beijing) Co Ltd Class A has paid dividends in 4 of them.
- Dividends of CN¥0.49 are expected for the next 12 months. This corresponds to a dividend yield of 0.53%.
- Eyebright Medical Technology (Beijing) Co Ltd Class A is assigned to the sector "Health Care".
- The last stock split of Eyebright Medical Technology (Beijing) Co Ltd Class A was on 5 June 2024 in the ratio 2:1.
- To receive the last dividend of Eyebright Medical Technology (Beijing) Co Ltd Class A on 5 June 2024 in the amount of CN¥0.49 you had to have the stock in your portfolio before the ex-day on 5 June 2024.
- The last dividend was paid on 5 June 2024.
- In 2022, dividends of CN¥0.21 were paid by Eyebright Medical Technology (Beijing) Co Ltd Class A.
- Dividends from Eyebright Medical Technology (Beijing) Co Ltd Class A are paid in Chinese Yuan.
- The headquarters of Eyebright Medical Technology (Beijing) Co Ltd Class A is located in China.